Venture Capital

Atlas Ocean Voyages' new Atlas Adventurer combines 1930s glamour with cutting-edge green tech. But can it truly chart a new course for sustainable travel?

As indoor farming pioneer Gotham Greens marks 15 years, a new CEO from the CPG world signals a bold strategy to conquer the entire fresh food aisle.

Doug DeMuro's online auction powerhouse Cars & Bids partners with Velocity Invitational for a groundbreaking on-site auction at Sonoma Raceway.

The XVIII Airborne Corps is tackling system chaos with a new contract, aiming to link disparate sensors and drones into a single, cohesive fighting network.

Once a simple commodity, automotive fasteners are now a $31B high-tech market. Discover how these critical components are enabling EV range and vehicle safety.

New data reveals nearly 4 in 10 women lack key vaginal bacteria linked to fertility, sparking a new conversation about an invisible factor in conception.

Patients, doctors, and researchers unite for a grueling ride across Iceland, raising funds and hope for a future free from multiple myeloma.

Deep-tech firm AHOY surpasses $100M ARR with its "Real-World AI," now seeking major funding to expand its sovereign AI for critical infrastructure.

Biopharma veteran Glenn Gormley joins Aktis's board, bringing deep ADC expertise to guide the company's next-gen radiopharmaceutical pipeline.

Purdue President Mung Chiang will chair FESI, a key nonprofit tasked with turning U.S. lab breakthroughs into market-ready energy technologies.

As BC braces for another fire season, a major investment is scaling up AI and hardware to stop infernos from power lines and lightning before they ignite.

Exclaimer's new Workday integration automates email signatures from HR data, slashing IT workload and ending the risk of outdated employee information.

The AI platform, backed by EPIC Ventures, uses proprietary buyer interviews to turn research into revenue for clients like Intel, Verizon, and CDW.

San Diego's Blacksmith Medicines will present promising data on its FEN1 inhibitor, a new drug targeting a notoriously difficult class of enzymes.

The chipmaker is expanding beyond consumer electronics, launching a new IC family to power the next generation of high-precision industrial scanners and machine vision.

A new Army contract for TurbineOne's edge AI reveals a radical shift in military procurement, empowering soldiers to fast-track the tech they need.

PAD is set to go public via a SPAC deal, fueled by contracts with SpaceX and the DoD. We explore the tech, strategy, and market impact of this move.

A four-legged robot powered by physical AI is set to revolutionize heavy industry by tackling the welder shortage and bringing automation to the field.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.

From $1,300 DIY setups to $100K+ labs, a new guide offers a crucial roadmap for researchers navigating the complex, costly world of VR investment.